MENLO PARK, Calif. (AP) — In a story November 8 about Adverum Biotechnologies Inc.'s earnings — generated by Automated Insights using data ...
News
- Correction: Earns-Adverum Biotechnologies story
- Biotech news that matter for investors: Puma Biotechnology, Inc. (NYSE:PBYI), Clovis Oncology ...
Puma Biotechnology, Inc. (NYSE:PBYI) on November 15, 2016 announced ... Symposium (SABCS), December 6 – 10, 2016, in San Antonio, Texas.
- Puma Biotech Crashes After Diarrhea Risk is Linked to Breast Cancer Drug
In an abstract for the 2016 San Antonio Breast Cancer Symposium in December, Puma said it was using the anti-diarrheal medicine loperamide for ...
- Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity
Puma Biotechnology Inc (NYSE:PBYI) just announced its abstract for an upcoming 2016 San Antonio Breast Cancer Symposium (SABCS), which will ...
- Cholesterol drug shows promise to help reverse heart disease
The new ones are biotech drugs that are expensive to make — Repatha costs $14,000 a year and insurers often won't pay. They must be given as ...